All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @hannahkburrow on TikTok · 234s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @hannahkburrow's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Alright, let's do a little update. I have been on a GLP one for four weeks now.
  2. 0:04Terzepa tied on the lowest dose, two and a half milligrams.
  3. 0:08And I just left my one month check in appointment and I have lost 14 and a half pounds.
  4. 0:14I did lose a couple pounds of muscle mass, which I'm not thrilled about, obviously.
  5. 0:19And she was like, you really need to start lifting weights.
  6. 0:21And I'm like, I know, girl, I know. So I'm going to start doing that.
  7. 0:25She said just like 10 to 15 minutes a day to help preserve that and make sure I'm
  8. 0:28getting a protein in. I do feel like I am getting enough protein in because when
  9. 0:35you're a bariatric patient, when you've had weight loss surgery, you know, they
  10. 0:38hammer that into you of like, you've got to get protein protein protein.
  11. 0:42So protein is always the first thing I eat. Sometimes it's the only thing I eat.
  12. 0:46I don't eat any vegetables or carbs or anything else.
  13. 0:49If I get full off of the protein, so I'm doing good there.
  14. 0:53I know I need to drink more water.
  15. 0:55Like I said, in my first video where I was being open about starting,
  16. 0:58the turds, appetite, I was very nervous about the side effects from the shots.
  17. 1:04But I have had very minimal side effects.
  18. 1:08I've been nauseous just a couple times and it's when I've eaten something that's
  19. 1:11maybe like a little more fatty or if I've eaten too much, which that would kind of
  20. 1:16happen to me anyways, like just having weight loss surgery, just reacts differently.
  21. 1:20I have experienced some constipation the first like week, I would say I dealt with
  22. 1:25it more, but I've been very diligently taking magnesium and that has helped me a ton.
  23. 1:31Magnesium and then an espresso will always do the trick.
  24. 1:34You know what I'm saying?
  25. 1:35So I usually take my magnesium pills with my espresso in the morning and then a
  26. 1:41couple hours later, an hour later, I'm good to go.
  27. 1:44So that's been my only real complaint.
  28. 1:47My appetite has been super suppressed.
  29. 1:51I just where I just like don't feel like eating and like nothing sounds good.
  30. 1:55Sometimes things will sound good, but like I don't have like the craving for
  31. 1:58anything really and I've noticed that food noise, which is like, if you don't deal
  32. 2:02with food noise, count yourself as lucky.
  33. 2:05But the food noise is like gone.
  34. 2:08Like I'm not snacking just to snack.
  35. 2:11Like I'm only eating when I'm actually hungry.
  36. 2:14And when I know that I need to eat not when I am bored or whatever the case, maybe
  37. 2:20some things have given me the Ick.
  38. 2:23I call it like I've spit out food a lot.
  39. 2:26I feel like the last four weeks, my husband's like, what's wrong with you?
  40. 2:29But I'll literally take a bite of something and I'm like, I don't want that.
  41. 2:33Like it's like my body's like, no, we're not.
  42. 2:35We don't want this.
  43. 2:36The most recent thing was a piece of beef jerky.
  44. 2:38My husband was like, do you want to buy it?
  45. 2:40And I was like, yeah, high protein, like that'll be good.
  46. 2:42I'll take a bite and like usually I can eat beef jerky and have no problem.
  47. 2:47And I took a bite of it and I chewed it for one second.
  48. 2:49And I was like, like I can't, not that I was like going to throw up or anything,
  49. 2:54but it was just like, I was like, I don't want that.
  50. 2:55Like that doesn't taste good to me.
  51. 2:57That doesn't sound good to me.
  52. 2:59So I have had the Ick with some things.
  53. 3:02So it's been a little bit of a struggle because nothing sounding good is kind of
  54. 3:06tough because you want to have something that sounds good.
  55. 3:09But overall, I've been very pleased with my experience so far.
  56. 3:13I mean, 14 and a half pounds a month is fantastic.
  57. 3:16I'm only about 20 pounds away from my goal weight, 20, 25 pounds.
  58. 3:21So we kept me on the same dose that I'm on because we feel like that's working.
  59. 3:26And I haven't had really any side effects, so I want to stay with that.
  60. 3:30And then she was like, I feel like you need to go up next month.
  61. 3:32We can always do that to the next dose, which would be five milligrams.
  62. 3:35But for now I'm sticking with the lowest dose and I'm pleased with how it is working.
  63. 3:40And I will keep you guys posted.
  64. 3:42I've got some new recipes coming that are GLP one friendly.
  65. 3:45So I'm super excited about sharing those with you guys and very thankful that I found
  66. 3:49something that is helping me get my weight back down and really just stay on track with my health goals.

@hannahkburrow's tirzepatide weight loss claims, fact-checked

hannah | healthy-ish recipes

TikTok creator

63.5K viewsWatch on TikTok →

Quick answer

Hannah is a post-bariatric surgery patient using tirzepatide 2.5 mg weekly for weight recurrence, a use case that involves compounding physiological factors including altered GI anatomy, pre-existing hormonal changes from the surgery, and now a dual GIP/GLP-1 agonist mechanism. Her lean mass loss after four weeks warrants monitoring with DEXA or bioelectrical impedance and a structured resistance training program rather than minimal daily movement. Protein prioritization is appropriate, but exclusive protein eating without micronutrient supplementation is a meaningful risk for this population.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksCompounded TirzepatideProvider discussion
Start provider reviewReview Compounded Tirzepatide

Evidence signal

Source-backed review

Regulatory reality

Compounded Tirzepatide access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @hannahkburrow's tirzepatide weight loss claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Randomized trialTirzepatide evidence2022

Tirzepatide Once Weekly for the Treatment of Obesity

Primary SURMOUNT-1 trial source for tirzepatide weight-loss ranges and tolerability.

PubMed

Randomized trialTirzepatide evidence2024

Continued Treatment With Tirzepatide for Maintenance of Weight Reduction

Used for continuation, stopping, and maintenance questions after initial weight loss.

PubMed

Systematic reviewGLP-1 class evidence2025

Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference

A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.

PubMed

Systematic reviewGLP-1 class evidence2025

Discontinuing glucagon-like peptide-1 receptor agonists and body habitus

Used for pages discussing stopping therapy, weight regain, and long-term planning.

PubMed

Video claim decision path

Turn the claim into a safer next question

Direct answer

Compounded Tirzepatide should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Start the provider review

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Helpful context before the funnel

Tirzepatide video claims video hub

Compare nearby social claims before acting.

Review Compounded Tirzepatide

Move from claim context to product, safety, and access details.

Review method

See how FormBlends checks viral health claims.

Claim path

Keep researching this tirzepatide video claims cluster

Best for searchers deciding whether tirzepatide claims are stronger, safer, or more relevant than semaglutide claims.

View topic hubTirzepatide video claimsReview TirzepatideTreatment or product pathCompare GLP-1 optionsDeeper FormBlends guide

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@hannahkburrow's tirzepatide weight loss claims, fact-checked" from hannah | healthy-ish recipes. We read the clip as a TRT social video fact-checks claim about Compounded Tirzepatide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Hannah is a post-bariatric surgery patient using tirzepatide 2.

The reason this review is not generic is the source wording and the canonical claim label "trt one month update on my glp1 journey total loss is 14 5 lb." In this clip, the useful excerpt is: "Alright, let's do a little update." That wording changes the review because it points to Compounded Tirzepatide safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Tirzepatide Once Weekly for the Treatment of Obesity (2022), Continued Treatment With Tirzepatide for Maintenance of Weight Reduction (2024), and Tirzepatide for Obesity Treatment and Diabetes Prevention (2025), plus the creator's own wording. Compounded Tirzepatide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Lean mass loss during tirzepatide use is real: studies suggest 25-39% of total weight lost can come from lean tissue without resistance training (Wilding et al.
People who land here are usually comparing the Compounded Tirzepatide claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Compounded Tirzepatide guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Hannah is a post-bariatric surgery patient using tirzepatide 2.

FormBlends verdict

Compounded Tirzepatide safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the Compounded Tirzepatide guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Hannah is a post-bariatric surgery patient using tirzepatide 2.5 mg weekly for weight recurrence, a use case that involves compounding physiological factors including altered GI anatomy, pre-existing hormonal changes from the surgery, and now a dual GIP/GLP-1 agonist mechanism. Her lean mass loss after four weeks warrants monitoring with DEXA or bioelectrical impedance and a structured resistance training program rather than minimal daily movement. Protein prioritization is appropriate, but exclusive protein eating without micronutrient supplementation is a meaningful risk for this population.
  • Tirzepatide is a dual GIP/GLP-1 receptor agonist, not a GLP-1 alone. Its distinct mechanism explains why SURMOUNT-1 (Jastreboff et al., 2022, NEJM) showed stronger weight loss than older GLP-1 drugs.
  • Lean mass loss during tirzepatide use is real: studies suggest 25-39% of total weight lost can come from lean tissue without resistance training (Wilding et al., 2023, Obesity Reviews).

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compounded Tirzepatide decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the Compounded Tirzepatide guide, cost path, safety notes, and provider review before acting.

Review Compounded Tirzepatide

What You'll Learn

  • Tirzepatide is a dual GIP/GLP-1 receptor agonist, not a GLP-1 alone. Its distinct mechanism explains why SURMOUNT-1 (Jastreboff et al., 2022, NEJM) showed stronger weight loss than older GLP-1 drugs.
  • Lean mass loss during tirzepatide use is real: studies suggest 25-39% of total weight lost can come from lean tissue without resistance training (Wilding et al., 2023, Obesity Reviews).
  • 2.5 mg is a tolerance-building starting dose in the FDA approval pathway, not a maintenance dose. Most clinical trial efficacy data comes from 5-15 mg doses.
  • Post-bariatric patients on GLP-1 class drugs face compounded micronutrient deficiency risk. Eating only protein with suppressed appetite does not cover B12, iron, vitamin D, or zinc needs.
  • Magnesium's laxative effect is osmotic and real, but constipation management during GLP-1 therapy should be reviewed by a provider, not treated as a fixed self-care protocol.
  • Hannah's four-week results likely reflect both tirzepatide and her prior bariatric anatomy. These outcomes are not generalizable to people without surgical weight loss history.
  • Resistance training evidence supports two to three structured sessions weekly for lean mass preservation during caloric restriction, not 10-15 minutes of light daily activity (Bhasin et al., 2023, Journal of Clinical Endocrinology and Metabolism).

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @hannahkburrow actually say?

Hannah reported losing 14.5 pounds in four weeks on tirzepatide 2.5 mg, her first month on the medication. She also noted losing some muscle mass, which her provider flagged. She credited magnesium supplementation for managing constipation, described near-total appetite suppression and what she calls "food noise" disappearing, and mentioned that as a prior bariatric patient she already prioritizes protein first at every meal. She plans to stay on the starting dose rather than escalating to 5 mg next month.

Her tone is anecdotal and personal, not prescriptive. She is not telling viewers what to take or how much. That matters when evaluating whether her claims cause harm.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

hannah | healthy-ish recipes · TikTok creator

63.5K views on this video

one month update on my glp1 journey. total loss is 14.5 lb. #glp1 #trizepatide #wls #vsg #glp1tips #wlstips #wlsregain #gastricsleeve #bariatricsurgery

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about tirzepatide?

Tirzepatide is a dual GIP/GLP-1 receptor agonist, not a GLP-1 alone. Its distinct mechanism explains why SURMOUNT-1 (Jastreboff et al., 2022, NEJM) showed stronger weight loss than older GLP-1 drugs.

What does the video say about lean mass loss during tirzepatide use?

Lean mass loss during tirzepatide use is real: studies suggest 25-39% of total weight lost can come from lean tissue without resistance training (Wilding et al., 2023, Obesity Reviews).

What does the video say about 2.5 mg?

2.5 mg is a tolerance-building starting dose in the FDA approval pathway, not a maintenance dose. Most clinical trial efficacy data comes from 5-15 mg doses.

What does the video say about post-bariatric patients on glp-1 class drugs face compounded micronutrient deficiency?

Post-bariatric patients on GLP-1 class drugs face compounded micronutrient deficiency risk. Eating only protein with suppressed appetite does not cover B12, iron, vitamin D, or zinc needs.

What does the video say about magnesium's laxative effect?

Magnesium's laxative effect is osmotic and real, but constipation management during GLP-1 therapy should be reviewed by a provider, not treated as a fixed self-care protocol.

What does the video say about hannah's four-week results likely reflect both tirzepatide?

Hannah's four-week results likely reflect both tirzepatide and her prior bariatric anatomy. These outcomes are not generalizable to people without surgical weight loss history.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by hannah | healthy-ish recipes, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.